about
Relevance of Endoplasmic Reticulum Stress Cell Signaling in Liver Cold Ischemia Reperfusion InjuryPolyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injuryPredictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results.Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation.Prediction of the Total Liver Weight using anthropological clinical parameters: does complexity result in better accuracy?Long-term survival and cure model following liver resection for breast cancer metastases.Repeat Hepatectomy for Breast Cancer Liver Metastases.Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison.Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.Suitability of livers for transplantation when treated by normothermic machine perfusionGlycocalyx Preservation and NO Production in Fatty Livers-The Protective Role of High Molecular Polyethylene Glycol in Cold Ischemia InjuryAldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia InjuryOutcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastasesGraft Protection Against Cold Ischemia Preservation: An Institute George Lopez 1 and Histidine-tryptophan-ketoglutarate Solution AppraisalALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center StudyHepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study
P50
Q26745583-85694D2E-2CB3-494E-8B2D-04992E1D7DFDQ28066686-882A4B64-05F9-4995-8801-46D05A0B96BEQ39442279-A8DC518B-72EA-4FD7-ADAB-F63EDDB837DAQ40261480-CE2BD981-1DEF-42CF-8249-CCC10196905CQ40968577-895AF642-3EBB-4043-8D52-B6C1A274A1B3Q41516652-3679C6A5-AF1A-47CD-85EF-A22B88908FB7Q46980971-EF1D5CFE-3AFB-44D8-AD56-1332C06F066AQ47246520-9D8C381E-F5D6-4234-9C3A-E29ABB53A5D5Q49721558-B07926E2-60F6-4EDA-BBEB-072609C7092FQ50996676-920C90F6-11F5-41AB-B19A-4DB3E1E60E76Q52630845-B71EE423-15E5-40E7-80BD-BA7D21C3098CQ52922107-8B186E8F-32D5-4C6D-B614-61873122F5C5Q57118064-81D0A269-D4F6-4409-BD88-A81638BE8CCEQ57169789-049BDCD9-19F4-4A09-9748-AB2D3AD62500Q58717283-6099B910-EF43-4064-B053-9DEB9E9DEF5FQ88112464-F0613DAA-9903-4EF7-8BB9-B8CEEE194640Q88375252-0EC8F4D1-3235-43C9-83BC-A5EB9A726E39Q89459787-6CF11120-06B0-4C56-8469-95D7C1A107DEQ89712651-E24B0027-3B2A-45F1-9DCF-11FAC4C6EFEE
P50
description
researcher ORCID ID = 0000-0001-5040-5960
@en
name
Carlos Castro-Benitez
@ast
Carlos Castro-Benitez
@en
Carlos Castro-Benitez
@es
Carlos Castro-Benitez
@nl
type
label
Carlos Castro-Benitez
@ast
Carlos Castro-Benitez
@en
Carlos Castro-Benitez
@es
Carlos Castro-Benitez
@nl
prefLabel
Carlos Castro-Benitez
@ast
Carlos Castro-Benitez
@en
Carlos Castro-Benitez
@es
Carlos Castro-Benitez
@nl
P1153
55892801200
P21
P31
P496
0000-0001-5040-5960